These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25795454)

  • 1. Differences in Psychiatric Problems and Criminality Between Individuals Treated With Central Stimulants Before and After Adulthood.
    Rasmussen K; Palmstierna T; Levander S
    J Atten Disord; 2019 Jan; 23(2):173-180. PubMed ID: 25795454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
    Paslakis G; Schredl M; Alm B; Sobanski E
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):444-51. PubMed ID: 23864520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of attention-deficit hyperactivity disorder for the future of the child and the young].
    Penttilä J; Rintahaka P; Kaltiala-Heino R
    Duodecim; 2011; 127(14):1433-9. PubMed ID: 21888044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of untreated ADHD among adults: the role of stimulant medication.
    Goksøyr PK; Nøttestad JA
    Addict Behav; 2008 Feb; 33(2):342-6. PubMed ID: 17920777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients.
    Halmøy A; Fasmer OB; Gillberg C; Haavik J
    J Atten Disord; 2009 Sep; 13(2):175-87. PubMed ID: 19372500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant ADHD medication and risk for substance abuse.
    Chang Z; Lichtenstein P; Halldner L; D'Onofrio B; Serlachius E; Fazel S; Långström N; Larsson H
    J Child Psychol Psychiatry; 2014 Aug; 55(8):878-85. PubMed ID: 25158998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
    Faraone SV; Biederman J; Wilens TE; Adamson J
    Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outcome of hyperactive children].
    Messerschmitt P
    Rev Prat; 2002 Nov; 52(18):2009-12. PubMed ID: 12602167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication for attention deficit-hyperactivity disorder and criminality.
    Lichtenstein P; Halldner L; Zetterqvist J; Sjölander A; Serlachius E; Fazel S; Långström N; Larsson H
    N Engl J Med; 2012 Nov; 367(21):2006-14. PubMed ID: 23171097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
    Barkley RA; Fischer M; Smallish L; Fletcher K
    Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history.
    Murphy KR; Barkley RA; Bush T
    J Nerv Ment Dis; 2002 Mar; 190(3):147-57. PubMed ID: 11923649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
    Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
    JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD.
    Kantak KM; Dwoskin LP
    Pharmacol Biochem Behav; 2016 Jun; 145():24-6. PubMed ID: 27012495
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
    Pliszka SR
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):525-40, vii. PubMed ID: 10944655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
    Wilens TE; Faraone SV; Biederman J; Gunawardene S
    Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.